CSL appoints Deborah Waterhouse as CEO and Managing Director

CSL Limited has announced the appointment of Deborah Waterhouse as Chief Executive Officer and Managing Director, effective February 1, 2027. The decision follows an extensive global search conducted by the company's Board of Directors.

Waterhouse brings over 25 years of experience in managing global specialty pharmaceutical companies across the United States, the United Kingdom, Europe, and Australia. Since 2017, she has served as the CEO of ViiV Healthcare, a joint venture majority-owned by GSK, and holds the position of President of GSK Global Health.

CSL Chair Dr. Brian McNamee stated that the board's unanimous decision was based on Waterhouse's ability to grow complex businesses, renew pipelines, and manage international partnerships.